ReviewEndocrine2022
Controversy on the management of patients carrying RET p.V804M mutation.
Ali S Alzahrani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewEndocrine2022
Ali S Alzahrani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.